Bhi Migraine Tablet
NDC Package 62795-1019-3

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Bhi Migraine (acetic acid, araneus diadematus, asafetida, bryonia alba whole, tribasic calcium phosphate, activated charcoal, cinchona officinalis bark, marsdenia condurango bark, tubocurarine chloride, kalmia latifolia leaf, lycopodium clavatum spore, sodium sulfate, phosphoric acid, pulsatilla vulgaris, claviceps purpurea sclerotium, and silicon dioxide) tablets is at first sign of symptoms:Adults: 1 tablet every 1/2 to 1 hour until symptoms lessen, then continue with standard dosage. This formulation utilizes a tablet delivery system. Marketed by Medinatura Inc, this product is identified by NDC 62795-1019.

Identification & Billing

NDC Package Code
62795-1019-3
Package Description
1 BOTTLE in 1 CARTON / 100 TABLET in 1 BOTTLE
Product Code
62795-1019
11-Digit Billing Format
62795101903
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
1 EA

Clinical Specifications

Proprietary Name
Bhi Migraine
Non-Proprietary Name
Acetic Acid, Araneus Diadematus, Asafetida, Bryonia Alba Whole, Tribasic Calcium Phosphate, Activated Charcoal, Cinchona Officinalis Bark, Marsdenia Condurango Bark, Tubocurarine Chloride, Kalmia Latifolia Leaf, Lycopodium Clavatum Spore, Sodium Sulfate, Phosphoric Acid, Pulsatilla Vulgaris, Claviceps Purpurea Sclerotium, And Silicon Dioxide
Substance Name
Acetic Acid; Araneus Diadematus; Asafetida; Bryonia Alba Whole; Tribasic Calcium Phosphate; Activated Charcoal; Cinchona Officinalis Bark; Marsdenia Condurango Bark; Tubocurarine Chloride; Kalmia Latifolia Leaf; Lycopodium Clavatum Spore; Sodium Sulfate; Phosphoric Acid; Pulsatilla Vulgaris; Claviceps Purpurea Sclerotium; Silicon Dioxide; Strychnine Nitrate
Dosage Form
Tablet - A solid dosage form containing medicinal substances with or without suitable diluents.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
Pharmacologic Class
Usage Information
At first sign of symptoms:Adults: 1 tablet every 1/2 to 1 hour until symptoms lessen, then continue with standard dosage. Do not exceed 12 tablets in 24 hours.Standard dosage:Adults: 3 tablets per day, taking 1 tablet every 4 to 6 hours.For children under 18, consult your health professional.Allow tablets to dissolve completely in the mouth, do not swallow.

Regulatory & Marketing

Labeler Name
Medinatura Inc
Product Type
Human Otc Drug
Marketing Category
UNAPPROVED HOMEOPATHIC - A category specifying that a product is marketed as unapproved homeopathic product.
Start Marketing Date
01-01-2015
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 62795-1019-3 identifies a specific commercial package of 1 bottle in 1 carton / 100 tablet in 1 bottle of Bhi Migraine, a human over the counter drug labeled by Medinatura Inc. This product is billed for "EA" each discreet unit and contains an estimated amount of 1 billable units per package. This tablet is formulated for oral use and contains acetic acid; araneus diadematus; asafetida; bryonia alba whole; tribasic calcium phosphate; activated charcoal; cinchona officinalis bark; marsdenia condurango bark; tubocurarine chloride; kalmia latifolia leaf; lycopodium clavatum spore; sodium sulfate; phosphoric acid; pulsatilla vulgaris; claviceps purpurea sclerotium; silicon dioxide; strychnine nitrate as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Medinatura Inc on January 01, 2015. The current certification is valid through December 31, 2026.

How is this Medinatura Inc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 62795101903. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 1 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
62795-1019-3
11-Digit CMS (5-4-2)
62795-1019-03

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.